ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1184

Negative Association Between Testosterone Levels and Risk of Future Rheumatoid Factor Negative Rheumatoid Arthritis in Men

Mitra Pikwer1, Aleksander Giwercman2, Ulf Bergström1, Jan-Åke Nilsson3, Lennart T.H. Jacobsson3 and Carl Turesson3, 1Rheumatology, Department of Clinical Sciences, Malmö, Lund University, Malmö, Sweden, 2Reproductive Medicine Centre, Skåne University Hospital, Malmö, Sweden, 3Section of Rheumatology, Department of Clinical Sciences, Malmö, Lund University, Malmö, Sweden

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: hormones, pathogenesis, rheumatoid arthritis (RA) and rheumatoid arthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Rheumamtoid Arthritis - Human Etiology and Pathogenesis

Session Type: Abstract Submissions (ACR)

Background/Purpose:

Rheumatoid arthritis (RA) is a heterogeneous disease with female predominance. Sex hormones have been suggested to play a part in the pathogenesis. We have previously identified hormonal predictors (breast-feeding and early menopause) that influence predominantly rheumatoid factor (RF) negative RA in women. The increasing incidence with age of RA in men parallels age related drops in androgens. Lower levels of testosterone have been demonstrated in men with RA compared with controls, but it has not been known whether this pattern precedes the disease or if it is a consequence of inflammation.

Methods:

A nested case-control study was performed, using information and blood samples from a community based health survey performed between 1974 and 1992, which included 22 444 males. Blood samples were drawn between 8.00 and 10.00 a.m. after an overnight fast and stored at -20 degrees Celsius. Height and weight was measured and self-reported smoking habits were noted. Incident cases of RA were identified by linking the cohort to local and national RA-registers, and verified by a structured review of their medical records. Two controls for each validated case, matched for age, sex and year of screening, were selected from the health survey.  Testosterone (T), sex hormone-binding globulin (SHBG), follicle stimulating hormone (FSH) and luteinizing hormones (LH) were analysed with standard immunoassays. Free testosterone was calculated from T and SHBG levels.

Results:

Serum was available from 105 cases (mean age at diagnosis 59 years; median time from screening to RA diagnosis 12.7 years (range 1-28); 73 % RF positive at diagnosis or later) and 174 matched controls.  Mean age at screening was 46 years. Mean free and total T levels were lower in pre-RA cases compared to controls, in particular in the subset who subsequently developed RF negative RA. T correlated negatively with body mass index (BMI), and smokers had significantly higher levels of both free and total T, as well as FSH and LH. In conditional logistic regression models, adjusted for smoking and BMI, lower levels of T were associated with RF negative RA (Odds Ratio (OR): 0.31 per standard deviation (SD), 95% Confidence Interval (CI): 0.12-0.85), with a similar tendency for RA overall (OR: 0. 77 per SD; 95% CI: 0.52-1.12). The same patterns were seen for free T. The differences were more pronounced in individuals screened > 12.7 years before diagnosis. Compared to matched controls and adjusted for smoking, significantly higher levels of FSH were seen in pre-RF-negative RA cases (p=0.02), whereas FSH levels were lower in pre-RF-positive RA cases (p=0.02),

Conclusion:

Lower levels of total and free T were predictive of RF negative RA in men, adjusted for smoking and BMI. FSH levels were higher before onset of  RF-negative RA, indicating a hypothalamus-pituitary response to testicular dysfunction. By contrast, lower FSH levels were found before onset of  RF-positive RA, implicating an impaired hypothalamus-pituitary function as a possible factor in the pathogenesis of RF positive RA. Our results suggest that distinct hormonal patterns are associated with different phenotypes of RA, and that changes in androgens precede the onset of RA in men.


Disclosure:

M. Pikwer,
None;

A. Giwercman,
None;

U. Bergström,
None;

J. Nilsson,
None;

L. T. H. Jacobsson,
None;

C. Turesson,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/negative-association-between-testosterone-levels-and-risk-of-future-rheumatoid-factor-negative-rheumatoid-arthritis-in-men/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology